• MLKL Polymerization Triggers Lysosomal Permeabilization in N

  2026-05-11

  This study reveals that polymerized MLKL directly drives lysosomal membrane permeabilization (LMP), leading to the release of cathepsin B—a critical executor of necroptosis. The findings clarify the mechanistic link between MLKL activity, lysosomal disruption, and regulated cell death, with practical implications for targeting cathepsin B in apoptosis and inflammation research.

• Indole-3-pyruvic Acid: A Molecular Nexus in Plant and Human

  2026-05-10

  Explore the multifaceted roles of indole-3-pyruvic acid (IPA) in plant hormone biosynthesis and mammalian immune and cancer pathways. This article uniquely connects mechanistic insights with practical assay recommendations and highlights recent breakthroughs in IPA-related therapeutic research.

• 4-Ethylphenyl Sulfate (SKU B6051): Reliable Solutions for Tr

  2026-05-09

  This article provides scenario-driven, evidence-based guidance for deploying 4-Ethylphenyl sulfate (SKU B6051) in cell viability, proliferation, and neurobehavioral assays. By addressing common experimental challenges and integrating recent surface adsorption and biomarker research, we demonstrate how APExBIO’s high-purity compound enhances reproducibility and workflow confidence in gut-brain and renal dysfunction models.

• Annexin V-Cy5/DAPI Apoptosis Kit: Precision in Cell Death De

  2026-05-08

  The Annexin V-Cy5/DAPI Apoptosis Kit offers rapid, dual-parameter detection of apoptosis and necrosis, enabling robust cell death quantification. This apoptosis detection kit leverages phosphatidylserine externalization and DNA integrity as core biomarkers, supporting reproducible research in oncology and cell biology.

• Enhancing Cell Viability Assays with VX-765, Caspase-1 Inhib

  2026-05-08

  This article examines how VX-765, Caspase-1 inhibitor, potent and selective (SKU A8238), addresses common experimental challenges in cell viability and inflammation research. By leveraging scenario-driven Q&A and evidence-based insights, researchers can improve assay reproducibility, interpret cytokine modulation more precisely, and optimize workflow efficiency with VX-765.

• SR-202: Precision PPARγ Antagonism for Metabolic Research

  2026-05-07

  SR-202 (PPAR antagonist) enables selective, reproducible inhibition of PPARγ-driven pathways, making it a cornerstone for advanced insulin resistance and obesity research. Its high solubility and specificity empower researchers to dissect metabolic and immunological mechanisms with unmatched control.

• Pemetrexed in Cancer Chemotherapy Research: Protocols & Insi

  2026-05-07

  Pemetrexed disodium empowers oncology researchers with robust, multi-targeted antifolate activity, enabling precise investigation into tumor cell vulnerabilities. This guide translates the latest gene expression and workflow advances into actionable protocols, troubleshooting tactics, and strategic enhancements for cancer chemotherapy research.

• CH 223191 in Environmental Toxicology: Mechanistic Depth & N

  2026-05-06

  Explore how CH 223191, a potent aryl hydrocarbon receptor antagonist, enables advanced mechanistic studies in environmental toxicology and regenerative biology. This article uniquely dissects practical assay design, reference innovations, and new experimental perspectives.

• Cy5 NHS ester(Et): Technical Guidance for Fluorescent Labeli

  2026-05-06

  Cy5 NHS ester(Et) enables efficient, water-soluble fluorescent labeling of primary amines in proteins and other biomolecules for detection and imaging workflows. It is not suitable for ethanol-based protocols or for long-term storage of working dye solutions. Researchers should adhere to recommended solubilization and handling practices to ensure reliable and reproducible results.

• Selective Magnetic Stimulation Modulates GABAA ε to Reverse

  2026-05-05

  This study demonstrates that precise magnetic stimulation targeting the left prelimbic cortex downregulates the GABAA receptor ε subunit, thereby reversing schizophrenia-like behaviors and synaptic abnormalities in murine models. The findings provide a mechanistic foundation for new neuromodulation strategies and highlight molecular targets relevant for advanced schizophrenia research.

• Nicotine Signaling Drives CKD Progression via Oxidative Stre

  2026-05-05

  Jain and Jaimes’ review delineates the mechanistic role of nicotine, acting through non-neuronal nicotinic acetylcholine receptors, in accelerating chronic kidney disease (CKD) progression. By integrating clinical and preclinical evidence, the study underscores the contribution of nicotine-induced oxidative stress and pro-fibrotic signaling to renal injury, opening avenues for targeted intervention strategies.

• Indole-3-pyruvic Acid: Bridging Auxin Regulation and Immune

  2026-05-04

  This thought-leadership article advances the discussion around Indole-3-pyruvic acid (IPA), illuminating its mechanistic roles in plant auxin biosynthesis and mammalian immune regulation. Translational researchers will find strategic guidance on leveraging IPA’s nuanced feedback control of TAA1 in plant systems, its modulation of the aryl hydrocarbon receptor (AhR) in mammals, and actionable parameters for designing robust experimental workflows. By integrating new feedback insights with practical assay optimization and cross-domain implications, this piece moves beyond conventional product literature and positions IPA as a critical probe for both plant hormone research and immunology.

• LL-37 and Mimetics: Antibiofilm Activity Assessed by Crystal

  2026-05-04

  This study investigates the biocidal and antibiofilm properties of the human host defense peptide LL-37 and its truncated mimetics, KE-18 and KR-12, against common biofilm-forming pathogens. By utilizing both crystal violet staining and XTT assays, the research delineates the nuanced relationships between antimicrobial and antibiofilm actions, offering insights for next-generation anti-infective strategies.

• Bradykinin: Technical Guidance for Endothelium-Dependent Vas

  2026-05-03

  Bradykinin (SKU BA5201) is a research-grade endothelium-dependent vasodilator peptide designed for use in experimental models investigating vascular permeability, smooth muscle contraction, pain mechanisms, and inflammation signaling. It is appropriate for controlled laboratory workflows but should not be used in diagnostic or clinical settings due to its intended research-only specification and stability limitations in solution.

• Merbromin as a Selective Mixed-Type Inhibitor of SARS-CoV-2

  2026-05-02

  This article reviews the discovery that merbromin acts as a selective, mixed-type inhibitor of the SARS-CoV-2 3-chymotrypsin-like protease (3CLpro), a key viral enzyme required for replication. The study's high-throughput screening and mechanistic analysis provide a scaffold for future antiviral drug development, with implications for targeted inhibitor design.

500 records 15/34 page Previous Next First page 上5页 1112131415 下5页 Last page